Lumigan Ganfort — Net revenues
Products & Services · Net revenuesAbbVie Lumigan Ganfort — Net revenues increased by 7.2% to $104.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 12.6%, from $119.00M to $104.00M. Over 4 years (FY 2021 to FY 2025), Lumigan Ganfort — Net revenues shows a downward trend with a -8.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong market retention or successful pricing strategies for these established products, while a decrease may signal increased generic competition or a shift in market preference toward newer therapeutic alternatives.
Detailed definition
This metric represents the total net sales generated from the Lumigan and Ganfort product line, which are ophthalmic sol...
Peer comparison
Comparable to revenue metrics for mature, branded pharmaceutical franchises or specific therapeutic product lines in the ophthalmology sector at peer pharmaceutical companies.
abbv_segment_lumigan_ganfort_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $149.00M | $138.00M | $149.00M | $140.00M | $130.00M | $121.00M | $123.00M | $130.00M | $119.00M | $91.00M | $92.00M | $91.00M | $103.00M | $116.00M | $119.00M | $106.00M | $103.00M | $97.00M | $104.00M |
| QoQ Change | — | -7.4% | +8.0% | -6.0% | -7.1% | -6.9% | +1.7% | +5.7% | -8.5% | -23.5% | +1.1% | -1.1% | +13.2% | +12.6% | +2.6% | -10.9% | -2.8% | -5.8% | +7.2% |
| YoY Change | — | — | — | — | -12.8% | -12.3% | -17.4% | -7.1% | -8.5% | -24.8% | -25.2% | -30.0% | -13.4% | +27.5% | +29.3% | +16.5% | +0.0% | -16.4% | -12.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's lumigan ganfort — net revenues?
- AbbVie (ABBV) reported lumigan ganfort — net revenues of $104.00M in Q4 2025.
- How has AbbVie's lumigan ganfort — net revenues changed year-over-year?
- AbbVie's lumigan ganfort — net revenues decreased by 12.6% year-over-year, from $119.00M to $104.00M.
- What is the long-term trend for AbbVie's lumigan ganfort — net revenues?
- Over 4 years (2021 to 2025), AbbVie's lumigan ganfort — net revenues has grown at a -8.3% compound annual growth rate (CAGR), from $579.00M to $410.00M.
- What does lumigan ganfort — net revenues mean?
- The total revenue generated from the sales of Lumigan and Ganfort eye care products.